[
    [
        {
            "time": "",
            "original_text": "2.37亿元溢价近10倍收购亏损企业，乐普医疗转战隐形正畸赛道能否分得一杯羹？亏损",
            "features": {
                "keywords": [
                    "乐普医疗",
                    "溢价收购",
                    "亏损企业",
                    "隐形正畸",
                    "高溢价"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "2.37亿元溢价近10倍收购亏损企业，乐普医疗转战隐形正畸赛道能否分得一杯羹？亏损",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        }
    ]
]